KANKER INST NL has a total of 13 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are NIPPON INST FOR BIOLOG SCIENCE, THEREXSYS LTD and BETHPHAGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Animal care | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Plasterk Ronald Hans Anton | 10 |
#2 | Schouten Govert Johan | 5 |
#3 | Valerio Domenico | 5 |
#4 | Luenen Hendricus Gerhard A Van | 4 |
#5 | Vos Jan Christiaan | 3 |
#6 | Gil Gomez Gabriel | 2 |
#7 | Jansen Gerrit | 2 |
#8 | Meijer Laurent | 2 |
#9 | Berns Antonius Jozef Maria | 2 |
#10 | Brady Hugh Joseph Martin | 2 |
Publication | Filing date | Title |
---|---|---|
EP1003899A1 | Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells | |
EP0911634A1 | Pharmaceutical uses of CDK-2 regulators | |
AU1674697A | Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |